An in vivo comparative clinical and radiographic evaluation of a mixture of zinc oxide–Ocimum sanctum extract, zinc oxide–ozonated oil, and zinc oxide–eugenol as obturating materials in primary molars

Abstract

Background: To overcome some of the disadvantages of the current primary root canal obturating materials, there is a continued interest in search for chemical compounds with broader and more effective antibacterial action and less cytotoxicity. Aim: This study aimed to evaluate and compare in vivo the clinical and radiographic success of mixtures of zinc oxide–Ocimum sanctum extract, zinc oxide–ozonated oil, and zinc oxide–eugenol (ZOE) as obturating materials in pulpectomy of primary molars. Settings and Design: This was an in vivo randomized controlled clinical trial. Materials and Methods: Ninety primary molars selected were randomly divided into three groups. Group A was obturated with zinc oxide–O. sanctum extract, Group B with zinc oxide–ozonated oil, and Group C with ZOE. All the groups were evaluated for success or failure based on clinical and radiographic criteria at the end of 1, 6, and 12 months. Statistical Analysis Used: The intra- and inter-examiner reliability of the first and the second co-investigators was calculated by Cohen's kappa statistic. The data were analyzed using Chi-square test, P ≤ 0.05 (indicates statistical significance). Results: By the end of 12 months, the overall clinical success rate was 88%, 95.7%, and 90.9% in Groups A, B, and C, respectively; whereas the radiographic success rate was found to be 80%, 91.3%, and 86.4% in Groups A, B, and C, respectively. Conclusion: On the basis of the overall success rates of all the three obturating materials, the following order of performance can be concluded: zinc oxide–ozonated oil > ZOE > zinc oxide–O. sanctum extract.

Keywords

• clinical success rate
• radiographic success rate
• zinc oxide–eugenol
• zinc oxide–ocimum sanctum extract
• zinc oxide–ozonated oil